CEO Panel | Anticipating Disruption | Planning for Widespread GCT - 2021 World Medical Innovation Forum
Boston
May 2–4, 2022

CEO Panel | Anticipating Disruption | Planning for Widespread GCT

CEO Panel | Anticipating Disruption | Planning for Widespread GCT

Thursday, May 20, 2021

12:05 PM – 12:30 PM

The power of GCT to cure disease has the prospect of profoundly improving the lives of patients who respond. Planning for a disruption of this magnitude is complex and challenging as it will change care across the spectrum. Leading chief executives shares perspectives on how the industry will change and how this change should be anticipated.

Moderator:
Meg Tirrell
  • Senior Health and Science Reporter, CNBC
Speakers:
Lisa Deschamps
  • SVP & Chief Business Officer, Novartis Gene Therapies
Kieran Murphy
  • CEO, GE Healthcare
Christian Rommel, PhD
  • EVP, Head, Pharmaceuticals Research & Development, Bayer AG
  • Q&A

    12:35 PM – 12:50 PM

the Future of Medicine and AI

May 11–13, 2020 | Boston, MA